openPR Logo
Press release

Myocardial Infarction Therapeutics Market Analysis, Segments, Growth and Value Chain 2016-2026

04-07-2016 11:35 AM CET | Health & Medicine

Press release from: FMI Reports

Myocardial Infarction Therapeutics Market Analysis,

Future Market Insights has announced the addition of the “Myocardial Infarction Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.

Myocardial infarction, generally called as heart attack is characterized by reduced blood supply to the heart muscles, primarily due to coronary artery disease. According to American Heart Association (AHA), every year around 17.3 Mn people die of heart diseases worldwide, with myocardial infarction being the leading cause of death. In 2012, British Heart Foundation reported 73,680 deaths in United Kingdom due to coronary heart disease. Mortality from acute myocardial infarction can be decreased if patient receives the emergency access to the treatment. The global cardiovascular treatment market generated a revenue of 170 Bn in 2010 and is expected to expand drastically over the forecast period of 2016-2026. Multitude of products available for the treatment of acute myocardial infarction with different indications include Zorprin, Plavix, Angiomax, Diovan, Lovenox, Aggrastat, NitroStat, Benicar and many more.

Myocardial Infarction Therapeutics Market: Drivers and Restraints

Increasing incidence of coronary artery disease and changes in lifestyle are the major factors expected to drive the growth of global myocardial infarction therapeutics market. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise can be some other reasons likely to flourish the global myocardial infarction therapeutics market over the forecast period of 2016-2026. WHO findings show that the death rate due to cardiovascular diseases is more in smokers than that in non-smokers. Whereas, saturation in R&D can be the major restraint for the growth of global myocardial infarction therapeutics market.

Myocardial Infarction Therapeutics Market: Segmentation

The global myocardial infarction therapeutics market has been classified on the basis product type, distribution channel and geography.

Based on product type, the global myocardial infarction therapeutics market is divided into following:

Analgesics

Antiplatelet agents

Vasodilators

Thrombolytics and anti-thrombotic agents

Glycoprotein IIb/IIIa inhibitors

Î’ adrenergic blockers

Angiotensin receptor antagonists

Angiotensin converting enzyme inhibitors

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1263

Based on distribution channel, the global blood canner treatment market is divided into following:

Hospitals

Hospital Pharmacies

Drug Stores

Online drug stores

Myocardial Infarction Therapeutics Market: Overview

Analgesics and antiplatelet agents’ segments are foreseen to hold more share in global myocardial infarction therapeutics market as these agents are used for initial treatment of an acute myocardial infarction. Amongst sales channels, hospital pharmacy segment is expected to contribute more into global myocardial infarction therapeutics market. The global myocardial infarction therapeutics market is foreseen to experience the boost in market volume over the forecast period due to the launch of several new products such as Apixaban, Xarelto and introduction of generic drugs after expiration of patents for Crestor and Benicar.

Myocardial Infarction Therapeutics Market: Regional Overview

Geographically, the global myocardial infarction terapeutic market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America will continue to take leading position in global myocardial infarction therapeutic market owing to expanding aging population and prevalence of co-morbidities. The expiry of blockbuster drugs in European market is likely to deter the segment share in global myocardial infarction therapeutics market. Japan is expected to experience the stagnancy in global myocardial infarction therapeutics market, in part due to saturation in R&D.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1263

Myocardial Infarction Therapeutics Market: Key Players

Some of the key players in global myocardial infarction therapeutics market are Novartis N.V., Daiichi Sankyo Company Limited, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, AstraZeneca, Apotex Inc., Sandoz, Par Pharmaceutical Companies, Inc., Mylan N.V., Pfizer Inc.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.

Mr. Sudip saha
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myocardial Infarction Therapeutics Market Analysis, Segments, Growth and Value Chain 2016-2026 here

News-ID: 330875 • Views: …

More Releases from FMI Reports

Research report covers the Triallyl Isocyanurate Market Growth, 2016-2026
Research report covers the Triallyl Isocyanurate Market Growth, 2016-2026
Future Market Insights has announced the addition of the “Triallyl Isocyanurate Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Triallyl isocyanurate is used as a cross linking in the manufacture of agrochemicals, flame retardants and synthetic rubbers. It is synthesized by gradually adding cyanuric chloride to excess of alcohol or allyl chloride in the presence concentrated aqueous phase. For various applications, triallyl isocyanurate can be…
Structured Cabling Market Growth and Segments,2016-2026
Structured Cabling Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Structured Cabling Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Structured cabling system is defined as the combination of set of cables & associated hardware used to provide comprehensive telecommunication infrastructure to various management systems, this telecommunication infrastructure enables the transmission of data, voice & video signal through a communication network from one point to other…
Polyetheramine Market, 2016-2026 by Segmentation: Based on Product, Based on Application and Region
Polyetheramine Market, 2016-2026 by Segmentation: Based on Product, Based on App …
Future Market Insights has announced the addition of the “Polyetheramine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Polyetheramines are typically the curing agents which contain polyether and amine moieties, are majorly used to increase toughness, flexibility, hydrophobicity or hydrophilicity of the end-products. Polyetheramines are used for a range of applications including polyurea, epoxy curing and polyamides in a range of coatings. Polyetheramines are also…
Immunochemistry Analyzer Market Regulations and Competitive Landscape Outlook to 2025
Immunochemistry Analyzer Market Regulations and Competitive Landscape Outlook to …
Future Market Insights has announced the addition of the “Immunochemistry Analyzer Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering. Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots. There are approximately more than 180,000 immunochemistry…

All 5 Releases


More Releases for Myocardial

Driving Myocardial Infarction Market Growth in 2025: The Role of Increasing Numb …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Myocardial Infarction Market Size Growth Forecast: What to Expect by 2025? Over the past few years, there has been a significant rise in the size of the myocardial infarction market. It is projected to expand from $2.05 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual…
Diabetes Epidemic Fuels Myocardial Ischemia Market Growth: An Emerging Driver Tr …
The Myocardial Ischemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Myocardial Ischemia Market? The myocardial ischemia market has grown strongly. It will grow from $0.79 billion in 2024 to $0.85 billion in 2025 at a CAGR of 7.3%.…
Transforming the Myocardial Ischemia Market in 2025: Diabetes Epidemic Fuels Myo …
What Is the Expected Size and Growth Rate of the Myocardial Ischemia Market? The market size for myocardial ischemia has demonstrated considerable growth over the last few years. There's a predicted growth from $0.79 billion in 2024 to $0.85 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The substantial growth during the historical period can be credited to the use of telemedicine and remote monitoring, the discovery…
Myocardial Infarction Treatment Market Growth and Insights 2024
"The Business Research Company recently released a comprehensive report on the Global Myocardial Infarction Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026". The Global market size of Myocardial Infarction Drugs Market was $XX…
Myocardial Ischemia - Pipeline Review, H1 2017 - Pharmaceutical Report
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm…